TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28236698

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 842
Study: 25498151

Group type: EXPERIMENTAL
Intervention: MOOC (massive open online course)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (self-paced online learning module)
Number of subjects: 48
Study: 23740664

Group type: EXPERIMENTAL
Intervention: PDT + surgery (4 sessions of topical PDT mediated with 20% 5-aminolevulinic acid)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 13
Study: 22080019

Group type: EXPERIMENTAL
Intervention: Corn
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Wheat
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Barley
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Lard
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Soy oil
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Acidulated vegetable soapstocks
Number of subjects: 756
Study: 18648764

Group type: EXPERIMENTAL
Intervention: Low-glycaemic index diet (Low-GI)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Low-carbohydrate/high-monounsaturated-fat diet (Low-CHO)
Number of subjects: 162

Group type: COMPARATOR
Intervention: High-carbohydrate/high-glycaemic index diet (High-GI)
Number of subjects: 162
Study: 16152600

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 5652

Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 5652
Study: 16117956

Group type: EXPERIMENTAL
Intervention: Daily visits for 1 month
Number of subjects: 618

Group type: COMPARATOR
Intervention: Weekly visits
Number of subjects: 618
Study: 10851671

Group type: EXPERIMENTAL
Intervention: Closed osteotomy using a cylindrical Shepard osteotome
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open osteotomy (control group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Closed harvesting group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open osteotomy group (control)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 9199724

Group type: EXPERIMENTAL
Intervention: Multimodal behavioural therapy (MBT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Psychiatric treatment based on a psychodynamic approach (PT)
Number of subjects: 35
Study: 1391144

Group type: EXPERIMENTAL
Intervention: Cisapride 30 mg/daily for two months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sucralfate 4 g/daily for two months
Number of subjects: 18
Study: 3900900

Group type: EXPERIMENTAL
Intervention: Hydralazine (2 mg/kg/day) for 3 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 31599826

Group type: EXPERIMENTAL
Intervention: Plug-unplug catheter
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Continuous drainage catheter
Number of subjects: 90

Group type: COMPARATOR
Intervention: Reference arm (discharged without a catheter)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Reference arm
Number of subjects: 90
Study: 30063903

Group type: EXPERIMENTAL
Intervention: Loop electrosurgical excision procedure
Number of subjects: 182

Group type: COMPARATOR
Intervention: Loop electrosurgical excision procedure–direct colposcopic vision
Number of subjects: 182
Study: 27388807

Group type: EXPERIMENTAL
Intervention: Patient Navigation intervention promoting Fecal Occult Blood Test (FOBT) and complementary exams
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 0
Study: 24681078

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy simulation
Number of subjects: 15566

Group type: COMPARATOR
Intervention: Fecal immunochemical testing (FIT)
Number of subjects: 15566
Study: 22196811

Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard biopsy forceps
Number of subjects: 140
Study: 20174838

Group type: EXPERIMENTAL
Intervention: Noncontiguous anterior decompression and fusion (NADF)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Contiguous corpectomies and fusion (CCF)
Number of subjects: 105
Study: 18032997

Group type: EXPERIMENTAL
Intervention: Vaginal lubricants (2 types of gels, suppositories) in addition to male and female condoms
Number of subjects: 301

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 301

Group type: COMPARATOR
Intervention: Group counseling
Number of subjects: 301

Group type: COMPARATOR
Intervention: Individual counseling
Number of subjects: 301
Study: 16446692

Group type: EXPERIMENTAL
Intervention: Heavy resistance training (RT)
Number of subjects: 17
Study: 12169890

Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgical simulator (ESS)
Number of subjects: 10
Study: 10889127

Group type: EXPERIMENTAL
Intervention: Intention to use EMS during a witnessed cardiac event
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Actual use of EMS
Number of subjects: 962

Group type: COMPARATOR
Intervention: Non-EMS users' behaviors
Number of subjects: 962
Study: 8744166

Group type: EXPERIMENTAL
Intervention: Threshold right unilateral (RUL) ECT
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Threshold bilateral (BL) ECT
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2.25 times threshold RUL ECT
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2.25 times threshold BL ECT
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (RUL ECT)
Number of subjects: 22
Study: 1302744

Group type: EXPERIMENTAL
Intervention: Structured psychosocial intervention (n = 13)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 24
Study: 3933197

Group type: EXPERIMENTAL
Intervention: Secretin (1 CU/Kg/h, 0 to 60 mins)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cholecystokinin (1 IU/Kg/h, 60 to 120 mins)
Number of subjects: 10

Group type: COMPARATOR
Intervention: NaCl infusion (control group during crossover study)
Number of subjects: 10
Study: 31002147

Group type: EXPERIMENTAL
Intervention: Diet P (enriched-polyunsaturated fat hypocaloric diet)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Diet M (enriched-monounsaturated fat hypocaloric diet)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Both diets (Diet P and Diet M)
Number of subjects: 363
Study: 30254412

Group type: EXPERIMENTAL
Intervention: Clip-flap group (ESD using an endoclip)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional group (ESD without an endoclip)
Number of subjects: 104
Study: 26343571

Group type: EXPERIMENTAL
Intervention: Statin choice decision aid
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 168
Study: 23792625

Group type: EXPERIMENTAL
Intervention: cTnT levels ≥0.01 ng/ml
Number of subjects: 1041
Study: 21885393

Group type: EXPERIMENTAL
Intervention: High-intensity noninvasive positive pressure ventilation (Hi-NPPV)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-intensity noninvasive positive pressure ventilation (Li-NPPV)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 15
Study: 20070958

Group type: EXPERIMENTAL
Intervention: Three between-subject conditions differing in how the group outcome was computed from individual players' answers.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structural Model (Chockler & Halpern, 2004)
Number of subjects: 0
Study: 18538118

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg
Number of subjects: 67

Group type: COMPARATOR
Intervention: Irbesartan 150 mg
Number of subjects: 67
Study: 15870092

Group type: EXPERIMENTAL
Intervention: Community nurse follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician-only follow-up
Number of subjects: 0
Study: 15314987

Group type: EXPERIMENTAL
Intervention: Ticlopidine (125 mg twice every 24h)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no Ticlopidine)
Number of subjects: 60
Study: 10229733

Group type: EXPERIMENTAL
Intervention: DCLHb (25, 50, and 100 mg/kg doses over 72 hours)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: DCLHb (100 mg/kg)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: DCLHb
Number of subjects: 85

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 85
Study: 8908453

Group type: EXPERIMENTAL
Intervention: In situ cooling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Warm ischaemia
Number of subjects: 20
Study: 29593022

Group type: EXPERIMENTAL
Intervention: Hospital at Home care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 0
Study: 25795013

Group type: EXPERIMENTAL
Intervention: LifeSkills Training (LST) + Strengthening Families Program: For Parents and Youth 10-14 (SFP 10-14)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: LifeSkills Training (LST) only
Number of subjects: 670

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 670
Study: 25561787

Group type: EXPERIMENTAL
Intervention: Biodegradable stent (BS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Endoscopic dilatation (ED)
Number of subjects: 17
Study: 22031525

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI) and Waist to Hip Ratio (WHR)
Number of subjects: 141652

Group type: EXPERIMENTAL
Intervention: Waist
Number of subjects: 141652

Group type: EXPERIMENTAL
Intervention: Waist to Height Ratio
Number of subjects: 141652

Group type: EXPERIMENTAL
Intervention: Adiposity measures
Number of subjects: 141652
Study: 20643002

Group type: EXPERIMENTAL
Intervention: LigaSure system (LS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional titanium clips and surgical ties (CLTs)
Number of subjects: 28
Study: 17571284

Group type: EXPERIMENTAL
Intervention: Sitagliptin 25 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitagliptin 400 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sitagliptin 25-400 mg
Number of subjects: 10
Study: 16392413

Group type: EXPERIMENTAL
Intervention: 3-month exercise program based on dance (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between exercise and control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise group satisfaction
Number of subjects: 40
Study: 12057734

Group type: EXPERIMENTAL
Intervention: Functional infertility group
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Functional infertility group (men)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (women)
Number of subjects: 142
Study: 9707305

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg once daily for three days)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cefaclor (30 mg/kg divided into three daily doses for ten days)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 122
Study: 8585766

Group type: EXPERIMENTAL
Intervention: Acetaminophen (650 mg every 4 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg every 4 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen, Aspirin, and Prednisone (as a group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Interferon alone)
Number of subjects: 0
Study: 2242782

Group type: EXPERIMENTAL
Intervention: Topical human leukocyte alpha-interferon 10(6) IU/g
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Topical human leukocyte alpha-interferon 10(4) IU/g
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 355958

Group type: EXPERIMENTAL
Intervention: Bromocriptine mesylate (2.5 mg twice daily for 14 days postpartum)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31386685

Group type: EXPERIMENTAL
Intervention: Assistive ironHand glove
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Therapeutic ironHand glove
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Assistive and therapeutic ironHand use
Number of subjects: 91

Group type: COMPARATOR
Intervention: Therapeutic group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 29087373

Group type: EXPERIMENTAL
Intervention: IC/BST stimulation
Number of subjects: 7

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: ITP stimulation
Number of subjects: 7
Study: 25157499

Group type: EXPERIMENTAL
Intervention: Nutribèn Pre
Number of subjects: 97

Group type: COMPARATOR
Intervention: Fortified human milk (FHM)
Number of subjects: 97
Study: 23623462

Group type: EXPERIMENTAL
Intervention: Training on fresh frozen cadavers (FFCs), 10 repetitions of structured laparoscopic tasks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Training on fresh frozen cadavers (FFCs)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 19
Study: 21729808

Group type: EXPERIMENTAL
Intervention: Insulin infusion to maintain BG level between 110 mg/dL and 126 mg/dL during surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no insulin therapy)
Number of subjects: 120
Study: 19458605

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg once daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 16317423

Group type: EXPERIMENTAL
Intervention: Passive walking-like exercise (PWE) in quadriplegics
Number of subjects: 13
Study: 14767445

Group type: EXPERIMENTAL
Intervention: Omalizumab (0.016 mg/kg per IgE (IU/mL))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11027921

Group type: EXPERIMENTAL
Intervention: Cocaine (20 mg or 40 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 14
Study: 9327081

Group type: EXPERIMENTAL
Intervention: Lead exposure measures (blood lead levels at the time of SVRT testing)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Lead exposure measures (recent and cumulative exposure measures)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Cumulative exposure measures
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: SVRT parameters (mean, median, truncated mean, and standard deviation)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: SVRT testing
Number of subjects: 284
Study: 8471512

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0
Study: 3302148

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 236

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 236

Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 236
Study: 31955461

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (DL‐PDT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional photodynamic therapy (c‐PDT) with blue light
Number of subjects: 26
Study: 29613883

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham ultrasound
Number of subjects: 37
Study: 27209269

Group type: EXPERIMENTAL
Intervention: Early initiation of renal replacement therapy (RRT) within 8 hours of diagnosis (n=112)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Delayed initiation of renal replacement therapy (RRT) within 12 hours of stage 3 AKI or no initiation (n=119)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Early initiation of RRT
Number of subjects: 231

Group type: COMPARATOR
Intervention: Delayed initiation of RRT
Number of subjects: 231
Study: 25189358

Group type: EXPERIMENTAL
Intervention: HPV 16/18 AS04-adjuvanted vaccine
Number of subjects: 5752

Group type: COMPARATOR
Intervention: Control
Number of subjects: 5752

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 5752
Study: 23768153

Group type: EXPERIMENTAL
Intervention: Case management vocational rehabilitation (VR) service
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 18
Study: 19925273

Group type: EXPERIMENTAL
Intervention: Home rehabilitation (HR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional care (CC)
Number of subjects: 102
Study: 18054942

Group type: EXPERIMENTAL
Intervention: Pioglitazone treatment (3 years)
Number of subjects: 61
Study: 15630733

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg twice a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12021690

Group type: EXPERIMENTAL
Intervention: Responders
Number of subjects: 666

Group type: COMPARATOR
Intervention: Nonresponders
Number of subjects: 666
Study: 10194223

Group type: EXPERIMENTAL
Intervention: N2O2 breathing (26% O2-balance N2) during heavy exercise
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HeO2 breathing (26% O2-balance He) during heavy exercise
Number of subjects: 6
Study: 8547380

Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation Unit (GEU) for comprehensive geriatric assessment (CGA)
Number of subjects: 123
Study: 2182255

Group type: EXPERIMENTAL
Intervention: AO dynamic hip screw
Number of subjects: 155

Group type: COMPARATOR
Intervention: Jewett nail plate
Number of subjects: 155
Study: 7373087

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 30651138

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily for 2 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo 200 mg once daily for 2 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 108
Study: 30989966

Group type: EXPERIMENTAL
Intervention: Bushen Culuan Decoction
Number of subjects: 90

Group type: COMPARATOR
Intervention: Estradiol valerate, Clomiphene, and Progesterone (Control)
Number of subjects: 90
Study: 28419834

Group type: EXPERIMENTAL
Intervention: Competitive condition
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Winners
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 112

Group type: COMPARATOR
Intervention: Non-competitive condition
Number of subjects: 112

Group type: COMPARATOR
Intervention: Losers
Number of subjects: 112

Group type: COMPARATOR
Intervention: Women
Number of subjects: 112
Study: 26814106

Group type: EXPERIMENTAL
Intervention: Intercostal nerve cryoanalgesia
Number of subjects: 71

Group type: COMPARATOR
Intervention: Intravenous analgesia
Number of subjects: 71
Study: 23014927

Group type: EXPERIMENTAL
Intervention: Intravenous atrial natriuretic peptide (ANP) at 0.03 μg/kg/min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (NTG) at 0.3 μg/kg/min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 14
Study: 21978409

Group type: EXPERIMENTAL
Intervention: Community-oriented, personal recruitment approach
Number of subjects: 1319

Group type: COMPARATOR
Intervention: Written invitations via general practitioners
Number of subjects: 1319

Group type: COMPARATOR
Intervention: Health care professional referrals
Number of subjects: 1319
Study: 18290862

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 233

Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: BIAsp 30 and IGlar
Number of subjects: 233
Study: 16796836

Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of autologous BM-MNC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline and heparin (Control)
Number of subjects: 40
Study: 12697853

Group type: EXPERIMENTAL
Intervention: Bestatin (30 mg daily for 2 years)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Placebo (daily for 2 years)
Number of subjects: 402
Study: 10955436

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 162
Study: 9117020

Group type: EXPERIMENTAL
Intervention: ABT‐761 (200 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8436457

Group type: EXPERIMENTAL
Intervention: Restricted postoperative instructions (limited activities and soft food liquid diet for 7-10 days)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Nonrestricted postoperative instructions (return to activity and diet as tolerated)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 92
Study: 3537093

Group type: EXPERIMENTAL
Intervention: Individually polymerized grass (IPG) immunotherapy with an accelerated dosage schedule (24,000 PNU over 9 weekly visits)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Caramelized glucose histamine placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Individually polymerized grass (IPG) immunotherapy
Number of subjects: 44
Study: 29197175

Group type: EXPERIMENTAL
Intervention: HPβCD-Diclofenac
Number of subjects: 0
Study: 27733403

Group type: EXPERIMENTAL
Intervention: 10 μg vitamin D3/d supplementation for 20 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 20 μg vitamin D3/d supplementation for 20 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: 0 μg vitamin D3/d (placebo) for 20 weeks
Number of subjects: 119
Study: 24850229

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups received fluvoxamine (100 mg/day for the first 4 weeks, then 200 mg/day for the rest of the trial)
Number of subjects: 46
Study: 22885123

Group type: COMPARATOR
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Phacoemulsification and intraocular lens implant (phaco/IOL)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Phaco/IOL
Number of subjects: 37

Group type: COMPARATOR
Intervention: LPI
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37